GAVISCON (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the GAVISCON drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
NON-PROPRIETARY NAME: | aluminum hydroxide and magnesium carbonate |
SUBSTANCE NAME: | ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2014-08-01 |
END MARKETING DATE: | 0000-00-00 |
GAVISCON HUMAN OTC DRUG Details:
Item Description | GAVISCON from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 254; 237.5(mg/5mL; mg/5mL) |
START MARKETING DATE: | 2014-08-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0135-0574_ede4661a-768d-4b5c-9eab-7ccfaea14b15 |
PRODUCT NDC: | 0135-0574 |
APPLICATION NUMBER: | part331 |
Other ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE Pharmaceutical Manufacturers / Labelers: